Technical Analysis for INKT - MiNK Therapeutics, Inc.

Grade Last Price % Change Price Change
F 0.71 -0.70% -0.01
INKT closed down 0.7 percent on Friday, November 1, 2024, on 74 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
20 DMA Support Bullish -0.70%
Hammer Candlestick Bullish -0.70%
Doji - Bullish? Reversal -0.70%
Overbought Stochastic Strength -0.70%
Down 3 Days in a Row Weakness -0.70%
50 DMA Resistance Bearish -1.66%

   Recent Intraday Alerts

Alert Time
20 DMA Resistance about 18 hours ago
10 DMA Resistance about 18 hours ago
Fell Below 20 DMA about 18 hours ago
20 DMA Support about 21 hours ago
Hammer Candlestick Entry about 21 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate includes AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immunology Pharmacy Stem Cell Cell Therapy T Cells Immune Mediated Diseases Natural Killer T Cell Lineage Cell Therapeutics

Is INKT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.9
52 Week Low 0.57
Average Volume 34,724
200-Day Moving Average 0.89
50-Day Moving Average 0.74
20-Day Moving Average 0.70
10-Day Moving Average 0.72
Average True Range 0.04
RSI (14) 46.81
ADX 23.14
+DI 12.60
-DI 19.29
Chandelier Exit (Long, 3 ATRs) 0.64
Chandelier Exit (Short, 3 ATRs) 0.69
Upper Bollinger Bands 0.75
Lower Bollinger Band 0.65
Percent B (%b) 0.61
BandWidth 13.59
MACD Line -0.01
MACD Signal Line -0.01
MACD Histogram 0.0057
Fundamentals Value
Market Cap 24.47 Million
Num Shares 34.5 Million
EPS -0.73
Price-to-Earnings (P/E) Ratio -0.97
Price-to-Sales 0.00
Price-to-Book 10.05
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.78
Resistance 3 (R3) 0.78 0.75 0.77
Resistance 2 (R2) 0.75 0.73 0.76 0.77
Resistance 1 (R1) 0.73 0.72 0.74 0.73 0.76
Pivot Point 0.70 0.70 0.71 0.71 0.70
Support 1 (S1) 0.68 0.69 0.69 0.68 0.66
Support 2 (S2) 0.65 0.67 0.66 0.65
Support 3 (S3) 0.63 0.65 0.65
Support 4 (S4) 0.63